Physician

Andrew L Rodenburg, M.D.

According to 2025 Medicare claims, Andrew Rodenburg, M.D. (NPI: 1003253634) practices ophthalmology in the Bismarck, ND market, with the plurality of this provider's patient population coming from Burleigh, ND. This provider's primary affiliated billing organization is DAKOTA EYE INSTITUTE PC (NPI: 1962449835; TIN: 450413089) and primary practice location at 58504-5675.

Rodenburg's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 707 traditional Medicare patients, billed 7,770 HCPCS/CPT codes, and received $609,667 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,099 prescription claims across 486 beneficiaries totaling $56,816 in drug costs, led by Lumigan (Bimatoprost). Open Payments data shows 6 records totaling $220. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $5,864 to $56,816. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$344K$689K2017 Medicare payment: $226,980 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $637,850 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $688,982 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $606,443 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $506,132 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $460,975 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $402,562 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $609,667 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
20173991,473$226,980
20188073,660$637,850
20198564,095$688,982
20207573,325$606,443
20218003,134$506,132
20226722,994$460,975
20236334,076$402,562
20247077,770$609,667

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$47K$94K2015 Drug cost: $5,864 (USD; Tot_Drug_Cst)2016 Drug cost: $3,549 (USD; Tot_Drug_Cst)2017 Drug cost: $15,966 (USD; Tot_Drug_Cst)2018 Drug cost: $43,617 (USD; Tot_Drug_Cst)2019 Drug cost: $60,675 (USD; Tot_Drug_Cst)2020 Drug cost: $89,437 (USD; Tot_Drug_Cst)2021 Drug cost: $94,107 (USD; Tot_Drug_Cst)2022 Drug cost: $68,812 (USD; Tot_Drug_Cst)2023 Drug cost: $56,414 (USD; Tot_Drug_Cst)2024 Drug cost: $56,816 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151739$5,864
20161527$3,549
2017118267$15,966
2018268682$43,617
2019280882$60,675
20203831,258$89,437
20214291,252$94,107
20223641,040$68,812
20234131,068$56,414
20244861,099$56,816

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more192205$81
92014Established patient complete exam of visual system293328$71
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more126156$55
92134Imaging of retina229442$27
92081Exam of visual field with limited testing153154$22

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
LumiganBimatoprost421,717$17,597
Prednisolone AcetatePrednisolone Acetate983,785$5,581
RhopressaNetarsudil Mesylate13325$4,121
LatanoprostLatanoprost21412,410$3,967
ErythromycinErythromycin Base3195,728$3,896

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.6$220Alcon Vision LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Andrew L. Rodenburg, M.D.?

Tedicare shows public-source Medicare data for Andrew L. Rodenburg, M.D. (NPI 1003253634), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Andrew L. Rodenburg, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Andrew L. Rodenburg, M.D.?

Andrew L. Rodenburg, M.D. is linked to DAKOTA EYE INSTITUTE PC (billing NPI 1962449835) in the available physician profile data.

Does Andrew L. Rodenburg, M.D. have Open Payments data?

Andrew L. Rodenburg, M.D. has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.